Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Sarah Elizabeth Wakeman, M.D.

Title
Institution
Department
Address
Phone

Biography
Brown UniversityBA05/2005Psychology
Brown Medical SchoolMD05/2009Medicine
Massachusetts General Hospital Internal Medicine Residency06/2012

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Weiner SG, Kobayashi K, Reynolds J, Chan K, Kelly R, Wakeman S, Reddy P, Young LD. Opioid Prescribing After Implementation of Single Click Access to a State Prescription Drug Monitoring Program Database in a Health System's Electronic Health Record. Pain Med. 2021 10 08; 22(10):2218-2223. PMID: 33561288.
    Citations:    Fields:    Translation:Humans
  2. Kiang MV, Barnett ML, Wakeman SE, Humphreys K, Tsai AC. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States. Drug Alcohol Depend. 2021 Sep 24; 228:109081. PMID: 34600256.
    Citations:    Fields:    
  3. Krenz JR, Hayes BD, Wakeman SE, Martin A, Raja AS, White BA, Koehl JL. Continuation of outpatient buprenorphine therapy after dispensing Buprenorphine-Naloxone from the emergency department. Clin Toxicol (Phila). 2021 Aug 19; 1-4. PMID: 34409916.
    Citations:    Fields:    
  4. Joyal K, Peckham AM, Wakeman SE, Zlotoff D, Lewis GD, D'Alessandro D, Crowley JC, Waldman G. Management of Opioid Agonist Treatment for Opioid use Disorder in the Setting of Solid Organ Transplant. Transplantation. 2021 Aug 16. PMID: 34406186.
    Citations:    Fields:    
  5. Weimer MB, Wakeman SE, Saitz R. X-Waiver Exemption in the Treatment of Opioid Use Disorder-Reply. JAMA. 2021 08 03; 326(5):442-443. PMID: 34342621.
    Citations:    Fields:    Translation:Humans
  6. DiGennaro C, Garcia GP, Stringfellow EJ, Wakeman S, Jalali MS. Changes in characteristics of drug overdose death trends during the COVID-19 pandemic. Int J Drug Policy. 2021 Jul 20; 98:103392. PMID: 34325184.
    Citations: 1     Fields:    
  7. Harris M, Joseph K, Hoeppner B, Wachman EM, Gray JR, Saia K, Wakeman S, Bair-Merritt MH, Schiff DM. A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation. J Addict Med. 2021 Jul-Aug 01; 15(4):311-317. PMID: 33060464.
    Citations:    Fields:    Translation:Humans
  8. Regan S, Howard S, Powell E, Martin A, Dutta S, Hayes BD, White BA, Williamson D, Kehoe L, Raja AS, Wakeman SE. Emergency Department-initiated Buprenorphine and Referral to Follow-up Addiction Care: A Program Description. J Addict Med. 2021 Jun 17. PMID: 34145185.
    Citations:    Fields:    
  9. Kemény LV, Robinson KC, Hermann AL, Walker DM, Regan S, Yew YW, Lai YC, Theodosakis N, Rivera PD, Ding W, Yang L, Beyer T, Loh YE, Lo JA, van der Sande AAJ, Sarnie W, Kotler D, Hsiao JJ, Su MY, Kato S, Kotler J, Bilbo SD, Chopra V, Salomon MP, Shen S, Hoon DSB, Asgari MM, Wakeman SE, Nestler EJ, Fisher DE. Vitamin D deficiency exacerbates UV/endorphin and opioid addiction. Sci Adv. 2021 Jun; 7(24). PMID: 34117054.
    Citations: 3     Fields:    
  10. Barnett BS, Wakeman SE, Davis CS, Favaro J, Rich JD. Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond. Am J Public Health. 2021 06; 111(6):1013-1017. PMID: 33950718.
    Citations:    Fields:    Translation:Humans
  11. DeWeese JP, Krenz JR, Wakeman SE, Peckham AM. Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: Titration, implementation barriers, and strategies to overcomes. Subst Abus. 2021 May 04; 1-6. PMID: 33945452.
    Citations:    Fields:    
  12. McNeely J, Adam A, Rotrosen J, Wakeman SE, Wilens TE, Kannry J, Rosenthal RN, Wahle A, Pitts S, Farkas S, Rosa C, Peccoralo L, Waite E, Vega A, Kent J, Craven CK, Kaminski TA, Firmin E, Isenberg B, Harris M, Kushniruk A, Hamilton L. Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics. JAMA Netw Open. 2021 May 03; 4(5):e2110721. PMID: 34014326.
    Citations: 1     Fields:    
  13. Weimer MB, Wakeman SE, Saitz R. Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough? JAMA. 2021 Mar 23; 325(12):1147-1148. PMID: 33630020.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  14. Olsen Y, Fitzgerald RM, Wakeman SE. Overcoming Barriers to Treatment of Opioid Use Disorder. JAMA. 2021 Mar 23; 325(12):1149-1150. PMID: 33630021.
    Citations: 1     Fields:    Translation:Humans
  15. Fine DR, Herzberg D, Wakeman SE. Societal Biases, Institutional Discrimination, and Trends in Opioid Use in the USA. J Gen Intern Med. 2021 03; 36(3):797-801. PMID: 32556873.
    Citations:    Fields:    Translation:HumansPHPublic Health
  16. Peckham AM, Kehoe LG, Gray JR, Wakeman SE. Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: A retrospective case series. J Subst Abuse Treat. 2021 07; 126:108316. PMID: 34116808.
    Citations:    Fields:    Translation:Humans
  17. Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML. Admission Practices And Cost Of Care For Opioid Use Disorder At Residential Addiction Treatment Programs In The US. Health Aff (Millwood). 2021 02; 40(2):317-325. PMID: 33523744.
    Citations: 1     Fields:    Translation:Humans
  18. Wakeman S, Flood J, Ciccarone D. Rise in Presence of Methamphetamine in Oral Fluid Toxicology Tests Among Outpatients in a Large Healthcare Setting in the Northeast. J Addict Med. 2021 Jan-Feb 01; 15(1):85-87. PMID: 32732682.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  19. Magidson JF, Regan S, Powell E, Jack HE, Herman GE, Zaro C, Kane MT, Wakeman SE. Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use. J Subst Abuse Treat. 2021 03; 122:108248. PMID: 33509420.
    Citations: 1     Fields:    Translation:Humans
  20. Wakeman SE, Kane M, Powell E, Howard S, Shaw C, Kehoe L, Rosen J, Quinlan J, Regan S. A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation. Subst Abus. 2020 Dec 03; 1-8. PMID: 33270549.
    Citations:    Fields:    
  21. Streck JM, Kalkhoran S, Bearnot B, Gupta PS, Kalagher KM, Regan S, Wakeman S, Rigotti NA. Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. Drug Alcohol Depend. 2021 01 01; 218:108438. PMID: 33271434.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  22. Martin A, Butler K, Chavez T, Herring A, Wakeman S, Hayes BD, Raja A. Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department. West J Emerg Med. 2020 Nov 02; 21(6):257-263. PMID: 33207174.
    Citations: 1     Fields:    Translation:Humans
  23. Shakir M, Wakeman S. Substance Use Disorder and Telemedicine: Opportunity and Concern for the Future. J Gen Intern Med. 2021 09; 36(9):2823-2824. PMID: 33078301.
    Citations: 2     Fields:    Translation:Humans
  24. Larochelle MR, Wakeman SE, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder: A Cohort Study. Med Care. 2020 10; 58(10):919-926. PMID: 32842044.
    Citations: 1     Fields:    Translation:Humans
  25. Wakeman SE, Rigotti NA, Herman GE, Regan S, Chang Y, Snow R, Isenberg B, Metlay JP. The effectiveness of post-discharge navigation added to an inpatient addiction consultation for patients with substance use disorder; a randomized controlled trial. Subst Abus. 2020 Sep 03; 1-8. PMID: 32881639.
    Citations: 2     Fields:    
  26. Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML. Therapies Offered at Residential Addiction Treatment Programs in the United States. JAMA. 2020 Aug 25; 324(8):804-806. PMID: 32840587.
    Citations: 3     Fields:    Translation:Humans
  27. Wakeman SE, Kane M, Powell E, Howard S, Shaw C, Regan S. Impact of Inpatient Addiction Consultation on Hospital Readmission. J Gen Intern Med. 2021 07; 36(7):2161-2163. PMID: 32572767.
    Citations: 1     Fields:    Translation:Humans
  28. Fiscella K, Beletsky L, Wakeman SE. Patients With Opioid Use Disorder Deserve Trained Providers. Ann Intern Med. 2020 06 02; 172(11):772-773. PMID: 32479153.
    Citations: 1     Fields:    Translation:Humans
  29. Wakeman SE, Green TC, Rich J. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nat Med. 2020 06; 26(6):819-820. PMID: 32555514.
    Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
  30. Wakeman SE. Diagnosis and Treatment of Opioid Use Disorder in 2020. JAMA. 2020 05 26; 323(20):2082-2083. PMID: 32329798.
    Citations: 2     Fields:    Translation:Humans
  31. Applewhite D, Regan S, Koenigs K, Mackin S, Schmidt C, Wakeman SE. Use of promethazine, gabapentin and clonidine in combination with opioids or opioid agonist therapies among individuals attending a syringe service program. Int J Drug Policy. 2020 Apr 21; 79:102752. PMID: 32330837.
    Citations: 1     Fields:    
  32. Fiscella K, Noonan M, Leonard SH, Farah S, Sanders M, Wakeman SE, Savolainen J. Drug- and Alcohol-Associated Deaths in U.S. Jails. J Correct Health Care. 2020 04; 26(2):183-193. PMID: 32314648.
    Citations:    Fields:    Translation:Humans
  33. Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O'Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians. Subst Abus. 2020 Apr 08; 1-9. PMID: 32267807.
    Citations: 1     Fields:    
  34. Schiff DM, Nielsen T, Terplan M, Wakeman SE, Yule AM, Mehta PK, Taveras EM, Wilens TE. IMPROVING MEASURES OF DYADIC OUTCOMES IN PERINATAL SUBSTANCE USE RESEARCH. Addiction. 2020 09; 115(9):1787-1788. PMID: 32143238.
    Citations:    Fields:    Translation:Humans
  35. Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open. 2020 02 05; 3(2):e1920622. PMID: 32022884.
    Citations: 45     Fields:    Translation:Humans
  36. Moreno JL, Duprey MS, Hayes BD, Brooks K, Khalil S, Wakeman SE, Roberts RJ, Jacobson JS, Devlin JW. Agreement between self-reported psychoactive substance use and urine toxicology results for adults with opioid use disorder admitted to hospital. Toxicol Commun. 2019; 3(1):94-101. PMID: 32051924.
    Citations:    
  37. Beletsky L, Wakeman SE, Fiscella K. Opioid Use Disorder in Physicians. Reply. N Engl J Med. 2019 12 05; 381(23):2281. PMID: 31801009.
    Citations: 1     Fields:    Translation:Humans
  38. Tsai AC, Kiang MV, Barnett ML, Beletsky L, Keyes KM, McGinty EE, Smith LR, Strathdee SA, Wakeman SE, Venkataramani AS. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med. 2019 11; 16(11):e1002969. PMID: 31770387.
    Citations: 32     Fields:    Translation:Humans
  39. Nielsen T, Bernson D, Terplan M, Wakeman SE, Yule AM, Mehta PK, Bharel M, Diop H, Taveras EM, Wilens TE, Schiff DM. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery. Addiction. 2020 02; 115(2):291-301. PMID: 31692133.
    Citations: 6     Fields:    Translation:Humans
  40. Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus. 2020; 41(4):519-525. PMID: 31638862.
    Citations: 19     Fields:    
  41. Snow RL, Simon RE, Jack HE, Oller D, Kehoe L, Wakeman SE. Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic. J Subst Abuse Treat. 2019 12; 107:1-7. PMID: 31757259.
    Citations: 15     Fields:    Translation:Humans
  42. Woodruff AE, Tomanovich M, Beletsky L, Salisbury-Afshar E, Wakeman S, Ostrovsky A. Dismantling Buprenorphine Policy Can Provide More Comprehensive Addiction Treatment. NAM Perspect. 2019; 2019. PMID: 34532670.
    Citations:    
  43. Beletsky L, Wakeman SE, Fiscella K. Practicing What We Preach - Ending Physician Health Program Bans on Opioid-Agonist Therapy. N Engl J Med. 2019 Aug 29; 381(9):796-798. PMID: 31461593.
    Citations: 3     Fields:    Translation:Humans
  44. Wakeman SE, Herman G, Wilens TE, Regan S. The prevalence of unhealthy alcohol and drug use among inpatients in a general hospital. Subst Abus. 2020; 41(3):331-339. PMID: 31368860.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  45. Martin A, Kunzler N, Nakagawa J, Lee B, Wakeman S, Weiner S, Raja AS. Get Waivered: A Resident-Driven Campaign to Address the Opioid Overdose Crisis. Ann Emerg Med. 2019 11; 74(5):691-696. PMID: 31272821.
    Citations: 6     Fields:    Translation:Humans
  46. Wakeman SE, Chang Y, Regan S, Yu L, Flood J, Metlay J, Rigotti N. Impact of Fentanyl Use on Buprenorphine Treatment Retention and Opioid Abstinence. J Addict Med. 2019 Jul/Aug; 13(4):253-257. PMID: 30550392.
    Citations: 6     Fields:    Translation:Humans
  47. Moreno JL, Wakeman SE, Duprey MS, Roberts RJ, Jacobson JS, Devlin JW. Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use Disorder. J Addict Med. 2019 Jul/Aug; 13(4):306-313. PMID: 30633044.
    Citations: 6     Fields:    Translation:Humans
  48. Beetham T, Saloner B, Wakeman SE, Gaye M, Barnett ML. Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality: An Audit Study. Ann Intern Med. 2019 07 02; 171(1):1-9. PMID: 31158849.
    Citations: 17     Fields:    Translation:Humans
  49. Fiscella K, Wakeman SE, Beletsky L. Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver. JAMA Psychiatry. 2019 03 01; 76(3):229-230. PMID: 30586140.
    Citations: 29     Fields:    Translation:Humans
  50. Walley AY, Wakeman SE, Eng G. Case 6-2019: A 29-Year-Old Woman with Nausea, Vomiting, and Diarrhea. N Engl J Med. 2019 02 21; 380(8):772-779. PMID: 30786192.
    Citations:    Fields:    Translation:HumansPHPublic Health
  51. Chen Q, Larochelle MR, Weaver DT, Lietz AP, Mueller PP, Mercaldo S, Wakeman SE, Freedberg KA, Raphel TJ, Knudsen AB, Pandharipande PV, Chhatwal J. Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States. JAMA Netw Open. 2019 02 01; 2(2):e187621. PMID: 30707224.
    Citations: 54     Fields:    Translation:Humans
  52. Wakeman SE, Rigotti NA, Chang Y, Herman GE, Erwin A, Regan S, Metlay JP. Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization. J Gen Intern Med. 2019 06; 34(6):871-877. PMID: 30632103.
    Citations: 10     Fields:    Translation:Humans
  53. Wakeman SE. 'Policies that Punish the Powerless' in a supply-led illicit fentanyl market. Addiction. 2019 05; 114(5):781-782. PMID: 30513550.
    Citations:    Fields:    Translation:Humans
  54. Ivkovic A, Wakeman S. Personal viewpoint on opioid agonist therapy and transplantation. Am J Transplant. 2018 12; 18(12):2869-2872. PMID: 30192432.
    Citations:    Fields:    Translation:Humans
  55. Jack HE, Oller D, Kelly J, Magidson JF, Wakeman SE. Asking How Our Patients Understand Addiction. Am J Med. 2019 03; 132(3):269-271. PMID: 30240683.
    Citations: 2     Fields:    Translation:Humans
  56. Fiscella K, Wakeman SE, Beletsky L. Implementing Opioid Agonist Treatment in Correctional Facilities. JAMA Intern Med. 2018 09 01; 178(9):1153-1154. PMID: 30073242.
    Citations: 4     Fields:    Translation:Humans
  57. Wakeman SE, Schiff DM, Gray J. Stigmatizing Language About Neonatal Abstinence Syndrome. JAMA. 2018 08 21; 320(7):722. PMID: 30140867.
    Citations:    Fields:    Translation:Humans
  58. Wakeman SE, Ladin K, Brennan T, Chung RT. Opioid Use Disorder, Stigma, and Transplantation: A Call to Action. Ann Intern Med. 2018 08 07; 169(3):188-189. PMID: 29987319.
    Citations:    Fields:    Translation:Humans
  59. Wakeman SE, Barnett ML. Primary Care and the Opioid-Overdose Crisis - Buprenorphine Myths and Realities. N Engl J Med. 2018 Jul 05; 379(1):1-4. PMID: 29972748.
    Citations: 34     Fields:    Translation:Humans
  60. Weinstein ZM, Wakeman SE, Nolan S. Inpatient Addiction Consult Service: Expertise for Hospitalized Patients with Complex Addiction Problems. Med Clin North Am. 2018 Jul; 102(4):587-601. PMID: 29933817.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  61. D'Couto HT, Robbins GK, Ard KL, Wakeman SE, Alves J, Nelson SB. Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial Therapy. Open Forum Infect Dis. 2018 May; 5(5):ofy056. PMID: 29766017.
    Citations: 10     
  62. Wakeman SE, Raja AS. Case 37-2017: A Man with Unintentional Opioid Overdose. N Engl J Med. 2018 03 01; 378(9):873. PMID: 29490179.
    Citations:    Fields:    Translation:Humans
  63. Bäck DK, Tammaro E, Lim JK, Wakeman SE. Massachusetts Medical Students Feel Unprepared to Treat Patients with Substance Use Disorder. J Gen Intern Med. 2018 03; 33(3):249-250. PMID: 28948479.
    Citations: 3     Fields:    Translation:Humans
  64. Martin A, Mitchell A, Wakeman S, White B, Raja A. Emergency Department Treatment of Opioid Addiction: An Opportunity to Lead. Acad Emerg Med. 2018 05; 25(5):601-604. PMID: 29266577.
    Citations: 11     Fields:    Translation:Humans
  65. Frank JW, Wakeman SE, Gordon AJ. No end to the crisis without an end to the waiver. Subst Abus. 2018; 39(3):263-265. PMID: 30676296.
    Citations: 7     Fields:    Translation:Humans
  66. Raja AS, Miller ES, Flores EJ, Wakeman SE, Eng G. Case 37-2017. A 36-Year-Old Man with Unintentional Opioid Overdose. N Engl J Med. 2017 Nov 30; 377(22):2181-2188. PMID: 29171813.
    Citations:    Fields:    Translation:Humans
  67. Jack HE, Oller D, Kelly J, Magidson JF, Wakeman SE. Addressing substance use disorder in primary care: The role, integration, and impact of recovery coaches. Subst Abus. 2018; 39(3):307-314. PMID: 28991516.
    Citations: 10     Fields:    Translation:Humans
  68. Wakeman SE, Rich JD. Barriers to Medications for Addiction Treatment: How Stigma Kills. Subst Use Misuse. 2018 01 28; 53(2):330-333. PMID: 28961017.
    Citations: 22     Fields:    Translation:Humans
  69. Wakeman SE. Why It's Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy. AMA J Ethics. 2017 Sep 01; 19(9):922-930. PMID: 28905733.
    Citations: 2     Fields:    Translation:Humans
  70. Wakeman SE. The Reply. J Addict Med. 2017 Jul/Aug; 11(4):331-332. PMID: 28759549.
    Citations:    Fields:    
  71. Wakeman SE, Kanter GP, Donelan K. Institutional Substance Use Disorder Intervention Improves General Internist Preparedness, Attitudes, and Clinical Practice. J Addict Med. 2017 Jul/Aug; 11(4):308-314. PMID: 28375881.
    Citations: 5     Fields:    
  72. Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction Severity. J Gen Intern Med. 2017 Aug; 32(8):909-916. PMID: 28526932.
    Citations: 47     Fields:    Translation:Humans
  73. Kaafarani HM, Weil E, Wakeman S, Ring D. The Opioid Epidemic and New Legislation in Massachusetts: Time For a Culture Change in Surgery? Ann Surg. 2017 Apr; 265(4):731-733. PMID: 27849666.
    Citations: 6     Fields:    Translation:Humans
  74. Wakeman SE. Another Senseless Death - The Case for Supervised Injection Facilities. N Engl J Med. 2017 Mar 16; 376(11):1011-1013. PMID: 28296603.
    Citations: 2     Fields:    Translation:Humans
  75. Fiscella K, Beletsky L, Wakeman SE. The Inmate Exception and Reform of Correctional Health Care. Am J Public Health. 2017 03; 107(3):384-385. PMID: 28177816.
    Citations: 2     Fields:    Translation:Humans
  76. Wakeman SE. The Reply. Am J Med. 2017 03; 130(3):e119. PMID: 28139206.
    Citations:    Fields:    
  77. Wakeman SE. Medications For Addiction Treatment: Changing Language to Improve Care. J Addict Med. 2017 Jan/Feb; 11(1):1-2. PMID: 27898497.
    Citations: 18     Fields:    Translation:Humans
  78. Wakeman SE, Pham-Kanter G, Donelan K. Attitudes, practices, and preparedness to care for patients with substance use disorder: Results from a survey of general internists. Subst Abus. 2016 Oct-Dec; 37(4):635-641. PMID: 27164025.
    Citations: 26     Fields:    Translation:Humans
  79. Wakeman SE. The Reply. Am J Med. 2016 10; 129(10):e251. PMID: 27671852.
    Citations:    Fields:    
  80. Wakeman SE, Rich JD. Barriers to Post-Acute Care for Patients on Opioid Agonist Therapy; An Example of Systematic Stigmatization of Addiction. J Gen Intern Med. 2017 01; 32(1):17-19. PMID: 27393486.
    Citations: 12     Fields:    Translation:Humans
  81. Saitz R, Wakeman SE, Kelly JF. The Integration of Care for Mental Health, Substance Abuse, and Other Behavioral Health Conditions Into Primary Care. Ann Intern Med. 2016 Mar 15; 164(6):447. PMID: 26974721.
    Citations:    Fields:    Translation:Humans
  82. Wakeman SE. Using Science to Battle Stigma in Addressing the Opioid Epidemic: Opioid Agonist Therapy Saves Lives. Am J Med. 2016 05; 129(5):455-6. PMID: 26836384.
    Citations: 3     Fields:    
  83. Kelly JF, Wakeman SE, Saitz R. The Reply. Am J Med. 2015 Jul; 128(7):e31. PMID: 26092077.
    Citations:    Fields:    Translation:Humans
  84. Wakeman SE, Rich JD. Substance use disorders and avoidable mortality after prison. Lancet Psychiatry. 2015 May; 2(5):369-370. PMID: 26069881.
    Citations:    Fields:    Translation:Humans
  85. Wakeman SE, Rich JD. Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care. J Addict Dis. 2015; 34(2-3):220-5. PMID: 26076211.
    Citations: 12     Fields:    Translation:Humans
  86. Noska A, Mohan A, Wakeman S, Rich J, Boutwell A. Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings. J Addict Behav Ther Rehabil. 2015; 4(2). PMID: 26258153.
    Citations: 9     
  87. Wakeman SE, Ghoshhajra BB, Dudzinski DM, Wilens T, Slavin PL. Case records of the Massachusetts General Hospital. Case 35-2014: a 31-year-old woman with fevers, chest pain, and a history of HCV infection and substance-use disorder. N Engl J Med. 2014 Nov 13; 371(20):1918-26. PMID: 25390743.
    Citations: 1     Fields:    Translation:Humans
  88. Wakeman SE, Pham-Kanter G, Baggett MV, Campbell EG. Medicine Resident Preparedness to Diagnose and Treat Substance Use Disorders: Impact of an Enhanced Curriculum. Subst Abus. 2015; 36(4):427-33. PMID: 25257796.
    Citations: 6     Fields:    Translation:Humans
  89. Kelly JF, Wakeman SE, Saitz R. Stop talking 'dirty': clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med. 2015 Jan; 128(1):8-9. PMID: 25193273.
    Citations: 21     Fields:    Translation:Humans
  90. Wakeman SE. One shot. J Gen Intern Med. 2014 Jun; 29(6):968-9. PMID: 24366396.
    Citations:    Fields:    Translation:Humans
  91. Wakeman SE, Green TC, Rich JD. From documenting death to comprehensive care: Applying lessons from the HIV/AIDS epidemic to addiction. Am J Med. 2014 Jun; 127(6):465-6. PMID: 24412918.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  92. Wakeman SE. Language and addiction: choosing words wisely. Am J Public Health. 2013 Apr; 103(4):e1-2. PMID: 23409913.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  93. Wakeman SE, Baggett MV, Pham-Kanter G, Campbell EG. Internal medicine residents' training in substance use disorders: a survey of the quality of instruction and residents' self-perceived preparedness to diagnose and treat addiction. Subst Abus. 2013; 34(4):363-70. PMID: 24159907.
    Citations: 14     Fields:    Translation:Humans
  94. Pace CA, Lioznov D, Cheng DM, Wakeman SE, Raj A, Walley AY, Coleman SM, Bridden C, Krupitsky E, Samet JH. Sexually transmitted infections among HIV-infected heavy drinkers in St Petersburg, Russia. Int J STD AIDS. 2012 Dec; 23(12):853-8. PMID: 23258823.
    Citations: 7     Fields:    Translation:Humans
  95. Wakeman SE. The one liner. Acad Med. 2011 Dec; 86(12):1555. PMID: 22130261.
    Citations:    Fields:    Translation:HumansCells
  96. Rich JD, Wakeman SE, Dickman SL. Medicine and the epidemic of incarceration in the United States. N Engl J Med. 2011 Jun 02; 364(22):2081-3. PMID: 21631319.
    Citations: 43     Fields:    Translation:HumansPHPublic Health
  97. Wakeman SE. Final moments. J Gen Intern Med. 2011 Jan; 26(1):98. PMID: 20697972.
    Citations:    Fields:    Translation:Humans
  98. Allen SA, Wakeman SE, Cohen RL, Rich JD. Physicians in US Prisons in the Era of Mass Incarceration. Int J Prison Health. 2010 Dec 01; 6(3):100-106. PMID: 22049298.
    Citations: 7     Fields:    
  99. Wakeman SE, Rich JD. HIV treatment in US prisons. HIV Ther. 2010 Sep 03; 4(4):505-510. PMID: 20953349.
    Citations: 12     
  100. Wakeman SE. Sitting with sorrow. Acad Med. 2010 Jun; 85(6):987. PMID: 20505398.
    Citations:    Fields:    Translation:Humans
  101. Wakeman SE, Rich JD. Fulfilling the mission of academic medicine: training residents in the health needs of prisoners. J Gen Intern Med. 2010 May; 25 Suppl 2:S186-8. PMID: 20352517.
    Citations: 6     Fields:    Translation:Humans
  102. Wakeman SE, Zaller ND, Flanigan TP, Pinkston M, Montague BT, Rich JD. HIV among marginalized populations in Rhode Island. Med Health R I. 2009 Jul; 92(7):244-6. PMID: 19685640.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  103. Wakeman SE, McKinney ME, Rich JD. Filling the gap: the importance of Medicaid continuity for former inmates. J Gen Intern Med. 2009 Jul; 24(7):860-2. PMID: 19381728.
    Citations: 33     Fields:    Translation:Humans
  104. Wakeman SE, Bowman SE, McKenzie M, Jeronimo A, Rich JD. Preventing death among the recently incarcerated: an argument for naloxone prescription before release. J Addict Dis. 2009; 28(2):124-9. PMID: 19340674.
    Citations: 22     Fields:    Translation:Humans
  105. Chan PA, Wakeman SE, Flanigan T, Cu-Uvin S, Kojic E, Kantor R. HIV-2 diagnosis and quantification in high-risk patients. AIDS Res Ther. 2008 Aug 14; 5:18. PMID: 18700986.
    Citations: 5     Fields:    
  106. Wakeman S, Benny P. Is it possible to predict a fertile cycle? Uteroovarian blood flow parameters in conception versus nonconception cycles. Fertil Steril. 2009 Jun; 91(6):2726-31. PMID: 18672235.
    Citations: 2     Fields:    Translation:Humans
  107. Wakeman SE. A piece of my mind. It's simple, really. JAMA. 2007 Nov 28; 298(20):2351. PMID: 18042908.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Wakeman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (240)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.